Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
GSK PLC |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 1,434.4 GBX | +0.13% | -0.11% | -0.22% | |
| Dec. 07 | European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading | MT |
| Dec. 07 | THG backer Kelso pushes for demerger to trim "inherent" valuation gap | AN |
Valuation
| Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 73 289 | 88 051 | 66 801 | 80 458 | 58 381 | 58 468 | - | - |
| Enterprise Value (EV) 1 | 94 910 | 113 773 | 87 581 | 100 296 | 75 578 | 73 724 | 70 908 | 67 653 |
| P/E ratio | 20,2x | 19,2x | 11,8x | 18,6x | 3,93x | 10,4x | 10,2x | 9,02x |
| Yield | 5,36% | 4,50% | 5,96% | 4,98% | 4,26% | 4,02% | 4,28% | 4,56% |
| Capitalization / Revenue | 2,38x | 2,61x | 1,96x | 2,36x | 1,99x | 1,97x | 1,88x | 1,77x |
| EV / Revenue | 3,08x | 3,37x | 2,57x | 2,94x | 2,58x | 2,49x | 2,28x | 2,05x |
| EV / EBITDA | 9,03x | 9,51x | 9,19x | 8,85x | 7,23x | 7,26x | 6,68x | 5,87x |
| EV / FCF | 16,7x | 22,4x | 16,2x | 22,6x | 12,1x | 13,6x | 10,7x | 9,18x |
| FCF Yield | 6,00% | 4,46% | 6,17% | 4,42% | 8,28% | 7,34% | 9,35% | 10,9% |
| Price to Book | 16,8x | 7,35x | 4,58x | 5,34x | 5,47x | 4,30x | 3,55x | 2,94x |
| Nbr of stocks (in thousands) | 3 931 836 | 3 959 572 | 3 982 185 | 4 006 383 | 4 060 999 | 4 076 145 | - | - |
| Reference price 2 | 18,6 | 22,2 | 16,8 | 20,1 | 14,4 | 14,3 | 14,3 | 14,3 |
| Announcement Date | 2/6/19 | 2/5/20 | 2/3/21 | 2/9/22 | 2/1/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 30 821 | 33 754 | 34 099 | 34 114 | 29 324 | 29 630 | 31 160 | 33 037 |
| EBITDA 1 | 10 508 | 11 968 | 9 530 | 11 330 | 10 449 | 10 151 | 10 610 | 11 524 |
| EBIT 1 | 8 745 | 8 972 | 8 906 | 8 806 | 8 151 | 8 702 | 9 065 | 10 010 |
| Operating Margin | 28,4% | 26,6% | 26,1% | 25,8% | 27,8% | 29,4% | 29,1% | 30,3% |
| Earnings before Tax (EBT) 1 | 4 800 | 6 221 | 6 968 | 5 442 | 5 628 | 7 444 | 7 836 | 8 606 |
| Net income 1 | 3 623 | 4 645 | 5 749 | 4 385 | 14 956 | 5 513 | 5 620 | 6 369 |
| Net margin | 11,8% | 13,8% | 16,9% | 12,9% | 51,0% | 18,6% | 18,0% | 19,3% |
| EPS 2 | 0,92 | 1,16 | 1,43 | 1,08 | 3,66 | 1,38 | 1,40 | 1,59 |
| Free Cash Flow 1 | 5 692 | 5 073 | 5 406 | 4 437 | 6 260 | 5 412 | 6 631 | 7 371 |
| FCF margin | 18,5% | 15,0% | 15,9% | 13,0% | 21,3% | 18,3% | 21,3% | 22,3% |
| FCF Conversion (EBITDA) | 54,2% | 42,4% | 56,7% | 39,2% | 59,9% | 53,3% | 62,5% | 64,0% |
| FCF Conversion (Net income) | 157% | 109% | 94,0% | 101% | 41,9% | 98,2% | 118% | 116% |
| Dividend per Share 2 | 1,00 | 1,00 | 1,00 | 1,00 | 0,61 | 0,58 | 0,61 | 0,65 |
| Announcement Date | 2/6/19 | 2/5/20 | 2/3/21 | 2/9/22 | 2/1/23 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period : December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8 092 | 9 077 | 9 527 | 9 780 | 6 929 | 7 829 | 7 376 | 6 951 | 7 178 | 8 147 | 7 540 | 7 080 | 7 300 | 8 140 | 7 810 |
| EBITDA 1 | 2 822 | 3 860 | 2 406 | 3 317 | 2 639 | 3 561 | 1 602 | 2 732 | 2 622 | 3 351 | 2 369 | - | - | - | - |
| EBIT 1 | 2 158 | 2 874 | 1 893 | 2 613 | 2 008 | 2 605 | 1 595 | 2 092 | 2 170 | 2 772 | 1 972 | 2 081 | 2 097 | 2 638 | 2 118 |
| Operating Margin | 26,7% | 31,7% | 19,9% | 26,7% | 29,0% | 33,3% | 21,6% | 30,1% | 30,2% | 34,0% | 26,2% | 29,4% | 28,7% | 32,4% | 27,1% |
| Earnings before Tax (EBT) 1 | 1 470 | 1 748 | 706 | 2 598 | 896 | 1 012 | 1 626 | 1 907 | 1 987 | 1 791 | 1 296 | - | - | - | - |
| Net income 1 | 1 395 | 1 168 | 749 | 1 802 | 975 | 10 315 | 1 495 | 1 490 | 1 624 | 1 464 | 1 323 | - | - | - | - |
| Net margin | 17,2% | 12,9% | 7,86% | 18,4% | 14,1% | 132% | 20,3% | 21,4% | 22,6% | 18,0% | 17,6% | - | - | - | - |
| EPS 2 | 0,35 | 0,29 | 0,18 | 0,45 | 0,21 | 2,52 | 0,37 | 0,37 | 0,40 | 0,36 | 0,32 | - | - | - | - |
| Dividend per Share 2 | 0,24 | 0,24 | 0,29 | 0,18 | 0,16 | 0,14 | 0,14 | 0,14 | 0,14 | 0,14 | 0,14 | 0,14 | 0,14 | 0,14 | 0,14 |
| Announcement Date | 7/28/21 | 10/27/21 | 2/9/22 | 4/27/22 | 7/27/22 | 11/2/22 | 2/1/23 | 4/26/23 | 7/26/23 | 11/1/23 | - | - | - | - | - |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period : December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 21 621 | 25 722 | 20 780 | 19 838 | 17 197 | 15 256 | 12 440 | 9 184 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2,06x | 2,15x | 2,18x | 1,75x | 1,65x | 1,50x | 1,17x | 0,80x |
| Free Cash Flow 1 | 5 692 | 5 073 | 5 406 | 4 437 | 6 260 | 5 412 | 6 631 | 7 371 |
| ROE (net income / shareholders' equity) | 273% | 75,0% | 44,4% | 38,2% | 43,9% | 50,5% | 43,1% | 39,7% |
| Shareholders' equity 1 | 1 325 | 6 191 | 12 951 | 11 472 | 34 104 | 10 913 | 13 049 | 16 030 |
| ROA (Net income/ Total Assets) | 10,3% | 8,90% | 7,18% | 5,50% | 8,08% | 9,59% | 9,85% | 10,5% |
| Assets 1 | 35 325 | 52 185 | 80 062 | 79 768 | 185 120 | 57 479 | 57 037 | 60 643 |
| Book Value Per Share 2 | 1,11 | 3,02 | 3,66 | 3,76 | 2,63 | 3,34 | 4,05 | 4,88 |
| Cash Flow per Share 2 | 2,12 | 2,00 | 2,09 | 1,96 | 1,81 | 1,87 | 1,98 | 2,28 |
| Capex 1 | 1 344 | 1 265 | 1 226 | 1 172 | 1 143 | 1 317 | 1 324 | 1 396 |
| Capex / Sales | 4,36% | 3,75% | 3,60% | 3,44% | 3,90% | 4,45% | 4,25% | 4,23% |
| Announcement Date | 2/6/19 | 2/5/20 | 2/3/21 | 2/9/22 | 2/1/23 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
14.34GBP
Average target price
17.27GBP
Spread / Average Target
+20.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.22% | 73 295 M $ | |
| +63.47% | 538 B $ | |
| +42.56% | 430 B $ | |
| -12.58% | 372 B $ | |
| -6.49% | 263 B $ | |
| -7.63% | 264 B $ | |
| +1.35% | 198 B $ | |
| -9.77% | 197 B $ | |
| -43.83% | 163 B $ | |
| +2.47% | 144 B $ |
- Stock
- Equities
- Stock GSK plc - London Stock Exchange
- Financials GSK plc
